1,402,022 filings since 2004 · latest accepted Nov 4, 2026, 7:13 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Jun 1, 2026 accepted 11:00 AM ET | ELOXEloxx Pharmaceuticals, Inc. | 3.02Unregistered equity sale3.03Holder rights modified5.02Officer / director change5.03Bylaws / fiscal year | DocumentSEC ↗ |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
ELOXEloxx Pharmaceuticals, Inc. |
3.03Holder rights modified5.03Bylaws / fiscal year5.07Shareholder vote8.01Other events |
| DocumentSEC ↗ |
Dec 22, 2017 accepted 1:31 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 2.01Acquisition / disposition3.02Unregistered equity sale3.03Holder rights modified4.01Auditor change5.01Change in control5.02Officer / director change5.03Bylaws / fiscal year8.01Other events | DocumentSEC ↗ |
May 7, 2015 accepted 12:05 AM ET | ELOXEloxx Pharmaceuticals, Inc. | 1.01Material agreement3.02Unregistered equity sale3.03Holder rights modified | DocumentSEC ↗ |
Jun 16, 2014 accepted 9:04 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 1.01Material agreement3.02Unregistered equity sale3.03Holder rights modified | DocumentSEC ↗ |
Feb 27, 2014 accepted 9:17 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 1.01Material agreement3.02Unregistered equity sale3.03Holder rights modified | DocumentSEC ↗ |
Mar 29, 2010 accepted 12:34 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 1.01Material agreement3.02Unregistered equity sale3.03Holder rights modified5.03Bylaws / fiscal year8.01Other events | DocumentSEC ↗ |